Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT05093673 Recruiting - Stroke Clinical Trials

Cerebellar Stimulation for Aphasia Rehabilitation

CeSAR
Start date: October 25, 2021
Phase: N/A
Study type: Interventional

The optimal site of neuromodulation for post-stroke aphasia has yet to be established. This study will investigate whether multiple sessions of cerebellar transcranial direct current stimulation (tDCS) boosts language therapy in helping people recover from aphasia as well as predict who is likely to respond to cerebellar tDCS.

NCT ID: NCT05093491 Completed - Respiratory Muscle Clinical Trials

Ultrasonographic Evaluation of Respiratory Muscles in Stroke Patients

Start date: December 25, 2020
Phase:
Study type: Observational [Patient Registry]

Ultrasonographic evaluation of respiratory muscle thickness in stroke patients, determination of its correlation with pulmonary function test (PFT) , and the first evaluation method to determine respiratory rehabilitation goals and to use it in the follow-up of the effectiveness of the treatment.

NCT ID: NCT05092139 Recruiting - Stroke, Ischemic Clinical Trials

Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)

Start date: January 21, 2022
Phase:
Study type: Observational [Patient Registry]

This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

NCT ID: NCT05091320 Not yet recruiting - Clinical trials for Stroke, Acute Ischemic

Mechanical Thrombectomy of Medium Sized Vessels "M2 of MCA".

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

Mechanical thrombectomy recently has revolutionized the treatment of stroke. Trials have demonstrated the superiority of mechanical thrombectomy in large vessel occlusions, such as in the intracranialinternal carotid artery and proximal, middle cerebral artery (M1), middle cerebral artery trunk (M1), have relatively high rates of revascularization and favorable clinical outcomes after MT. , However second-order branches of the middle cerebral artery (M2) occlusions (postbifurcation in the Sylvian fissure) were underrepresented or not represented in the trials. Posing a more significant technical challenge to the available endovascular devices because of the smaller size and tortuosity of these arteries and the greater likelihood of recanalization with intravenous thrombolysis, the overall risk-benefit remains uncertain.

NCT ID: NCT05090878 Recruiting - Ischemic Stroke Clinical Trials

Atherogenic Lipoproteins in Ischemic Stroke

AGELESS
Start date: September 20, 2021
Phase:
Study type: Observational

Apolipoprotein B (apoB) levels (which encompass all atherogenic lipoproteins, including LDL), Lp(a) levels, and carotid IPH are associated with both first-ever and recurrent ischemic stroke. This cohort research project is to analyze: 1. Among patients with carotid artery atherosclerosis (stenosis 30-99%), to compare patients with and without IPH, as assessed by magnetic resonance (MR)-Plaque Imaging, in terms of apoB, Lp(a) levels and other cardiovascular risk factors. (IPH is a strong morphological sign of plaque vulnerability / instability and a strong marker of consecutive atheroembolic events). 2. Among patients with carotid artery atherosclerosis (stenosis 30-99%), to assess the risk of first-ever ischemic stroke in relation to apoB, Lp(a) levels, and presence of IPH, after adjusting for the cardiovascular factors (understanding this association can inform primary prevention). 3. Among patients with carotid artery atherosclerosis (stenosis 30-99%) with an ipsilateral ischemic stroke at baseline, to assess the risk of recurrent ipsilateral ischemic stroke in relation to apoB, Lp(a) levels, and presence of IPH, after adjusting for the cardiovascular factors. There will be a sensitivity analysis to assess if the association between Lp(a) and recurrent stroke is stronger in patients <60 years of age. (understanding this association can inform secondary prevention). For the first and second aim, there will be a cross-sectional, case-control analysis. For the third aim, i.e. assessing recurrent ischemic stroke, there is prospective follow-up of at least 3 months up to 45 months.

NCT ID: NCT05090163 Completed - Stroke Clinical Trials

Prep Plus: Upper Limb Stroke Rehabilitation in the Community

Start date: January 19, 2022
Phase: N/A
Study type: Interventional

PREP Plus aims to create support for those who have survived stroke(s) and are still experiencing weakness in the upper limbs. In conjunction with the PREP programme, and based on the GRASP programme, the aim is to evaluate the feasibility, acceptability, and efficacy of an upper limb intervention support for survivors. Integration of an evidence based upper limb programme to an established physical activity programme will be a feasible method to support long term upper limb rehabilitation to community dwelling stroke survivors.

NCT ID: NCT05087719 Completed - Stroke Clinical Trials

Effects of Proprioceptive Activities on Hand Function in Chronic Stroke Patients

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

To determine effects of proprioceptive activities on hand function in chronic stroke patients

NCT ID: NCT05086874 Completed - Stroke Clinical Trials

Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients

Start date: May 7, 2022
Phase:
Study type: Observational

This is a retrospective, multi-center, real-world study. The researchers plan to include 10,000 cases of ischemic stroke patients using butylphthalide and 10,000 cases of ischemic stroke patients using Edaravone. The main purpose is to analyze the effectiveness and safety of butylphthalide and establish the drug risk assessment management plan.

NCT ID: NCT05086055 Recruiting - Stroke Clinical Trials

Rehabilitation of Stroke Patients for Maximal Neurological Restoration

PROTEQT
Start date: November 11, 2021
Phase:
Study type: Observational

Multimodal imaging of stroke patients. Patients included in the study will be investigated with multiparametric imaging tools including MRI and EEG imaging. Improvements in motor skills will be monitored clinically.

NCT ID: NCT05085210 Recruiting - Stroke Clinical Trials

Improving Visual Field Deficits With Noninvasive Brain Stimulation

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

This is a randomized, pilot interventional study in participants with visual field deficit (VFD) caused by cortical lesion. Damage to the primary visual cortex (V1) causes a contra-lesional, homonymous loss of conscious vision termed hemianopsia, the loss of one half of the visual field. The goal of this project is to elaborate and refine a rehabilitation protocol for VFD participants. It is hypothesized that visual restoration training using moving stimuli coupled with noninvasive current stimulation on the visual cortex will promote and speed up recovery of visual abilities within the blind field in VFD participants. Moreover, it is expected that visual recovery positively correlates with reduction of the blind field, as measured with traditional visual perimetry: the Humphrey visual field test. Finally, although results will vary among participants depending on the extension and severity of the cortical lesion, it is expected that a bigger increase in neural response to moving stimuli in the blind visual field in cortical motion area, for those participants who will show the largest behavioral improvement after training. The overarching goals for the study are as follows: Group 1 will test the basic effects of transcranial random noise stimulation (tRNS) coupled with visual training in stroke cohorts, including (i) both chronic and subacute VFD stroke participant, and (ii) longitudinal testing up to 6 months post-treatment. Group 2 will examine the effects of tRNS alone, without visual training, also including chronic and subacute VFD stroke participants and longitudinal testing.